United States

Afluria Quadrivalent®

Afluria Quadrivalent®, (Influenza Vaccine) Indication

AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. AFLURIA QUADRIVALENT is approved for use in individuals five years of age and older.1 

Important Safety Information for Consumers

What is Afluria┬« Quadrivalent Influenza Vaccine?

Afluria Quadrivalent is an inactivated (virus is not alive) influenza vaccine used for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine.

Afluria Quadrivalent cannot give you the flu. It stimulates the immune system to produce antibodies that can help to protect against influenza; the full effect of the vaccine is generally achieved approximately three weeks after receiving your vaccination. Annual vaccination is recommended against influenza.


Who should receive Afluria Quadrivalent?

Afluria Quadrivalent administered by needle and syringe can be used in patients 5 years of age and older. Afluria Quadrivalent can be used with the PharmaJet® Stratis® Needle-Free Injection System in patients 18 through 64 years of age.

Who should not receive Afluria Quadrivalent?

Do not receive Afluria Quadrivalent if you have an egg allergy. Talk with your doctor if you have ever had a severe allergic reaction after receiving a flu vaccine. Talk with your doctor if you have ever had Guillain-Barre Syndrome (GBS). Talk with your doctor if you get infections easily, are pregnant, or nursing.

What are the side effects of Afluria Quadrivalent?
  • The most common injection-related adverse reactions in children (5 through 8 years of age) administered Afluria Quadrivalent with needle and syringe were pain, redness, and swelling. The most common side effect was headache.
  • The most common injection-related adverse reactions in children (9 through 17 years of age) administered Afluria Quadrivalent with needle and syringe were pain, redness, and swelling. The most common side effects were headache, muscle pain, feeling tired and sick.
  • The most common injection-related adverse reactions in adults (18 through 64) administered Afluria Quadrivalent with needle and syringe was pain. The most common side effects in adults were muscle pain and headache.
  • In adults age 65 and older, when administered Afluria Quadrivalent by needle and syringe, the most common injection-related adverse reactions was pain. The most common side effect was muscle pain.
  • The most common injection-related adverse reactions in adults (18 through 64) administered Afluria Trivalent by the PharmaJet Stratis Needle-Free Injection System up to 7 days after vaccination were tenderness, swelling, pain, redness, itching, and bruising. The most common side effects were muscle pain, feeling tired and sick, and headache.

What do I do if I have side effects?
Report any severe or unusual side effects to your healthcare provider.
Please see full prescribing information for AFLURIA QUADRIVALENT for further information.To report SUSPECTED ADVERSE REACTIONS, contact Seqirus USA Inc. at 1-844-275-2461 or VAERS at 1-800-822- 7967 or www.vaers.hhs.gov.

The information presented on this site is intended for US residents only.
© 2018 Seqirus All rights reserved.
Seqirus is a trademark of CSL Limited.

BCSL14-02-0003 06/2014